Back to Search
Start Over
AstraZeneca's TAGRISSO plus chemotherapy results presented at ESMO
- Source :
- The Fly. October 22, 2023
- Publication Year :
- 2023
-
Abstract
- Results from a prespecified exploratory analysis of the FLAURA2 Phase III trial showed AstraZeneca's TAGRISSO with the addition of chemotherapy demonstrated a 42% improvement in central nervous system progression-free survival, [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.769897021